Home › NDC Lookup › RxCUI directory › RxCUI 2174095

Polatuzumab vedotin-piiq 140 MG Injection — RxCUI 2174095

RxNorm drug concept · Semantic clinical drug
RxCUI 2174095 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2174095
Official namePolatuzumab vedotin-piiq 140 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)698 prescriptions · 14 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Polatuzumab vedotin-piiq 140 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Polatuzumab vedotin-piiq 140 MG Injection RxCUI 2174095

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Polatuzumab vedotin 2174090
    • Polatuzumab vedotin-piiq 2174091
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Polivy 2174096
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Polatuzumab vedotin Injection 2174094
    • Polatuzumab vedotin-piiq Injection 2647227
    • Polatuzumab vedotin Injectable Product 2174093
    • Polatuzumab vedotin-piiq Injectable Product 2662338
    • Polatuzumab vedotin Injection [Polivy] 2174098
    • Polatuzumab vedotin-piiq Injection [Polivy] 2658956
    • Polivy Injectable Product 2174099
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Polatuzumab vedotin-piiq 140 MG SCDC · 2174092
  • Polatuzumab vedotin Injection SCDF · 2174094
  • Polatuzumab vedotin-piiq Injection SCDFP · 2647227
  • Polatuzumab vedotin Injectable Product SCDG · 2174093
  • Polatuzumab vedotin-piiq Injectable Product SCDGP · 2662338

Brand-Name Concepts

  • Polatuzumab vedotin-piiq 140 MG Injection [Polivy] SBD · 2174100
  • Polatuzumab vedotin-piiq 140 MG [Polivy] SBDC · 2174097
  • Polatuzumab vedotin Injection [Polivy] SBDF · 2174098
  • Polatuzumab vedotin-piiq Injection [Polivy] SBDFP · 2658956
  • Polivy Injectable Product SBDG · 2174099
  • Polivy BN · 2174096

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2174095 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50242-0103-01 1 VIAL in 1 CARTON (50242-103-01) / 6 mL in 1 VIAL POLIVY Genentech, Inc. 2020-09-18
50242-0105-01 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-105-01) / 20 mL in 1... POLIVY Genentech, Inc. 2019-06-10
Observed labelers: Genentech, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9309 Inj, polatuzumab vedotin 1mg 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.